Advertisement

Echothiophate Powder for Ophthalmic Solution

[26 June 2014]

Products Affected - Description

Phospholine Iodide 0.125%, Pfizer
5 mL bottle (NDC 00046-1065-05)

Reason for the Shortage

Pfizer is the only manufacturer of echothiophate powder for ophthalmic solution (Phospholine Iodide).

Available Products

Insufficient supplies for usual ordering.

Estimated Resupply Dates

Pfizer has product available through a limited distribution plan to physicians and pharmacists. Details for ordering can be obtained through Pfizer at 1-800-666-7248.

Related Shortages

Updated

June 26, 2014; May 14, 2014; March 25, 2014; January 8, 2014; October 28, 2013; August 12, 2013; May 30, 2013; March 6, 2013; December 14, 2012; September 19, 2012; June 29, 2012; March 30, 2012; January 27, 2012; November 15, 2011; September 27, 2011; August 5, 2011; July 18, 2011; May 9, 2011; March 8, 2011; January 26, 2011; December 2, 2010; October 26, 2010; August 18, 2010; June 22, 2010; April 27, 2010; February 26, 2010; January 20, 2010; November 11, 2009; September 22, 2009; July 31, 2009; May 4, 2009; March 4, 2009; January 29, 2009; January 9, 2009; December 15, 2008; August 8, 2008; July, 21, 2008; May 19, 2008; April 11, 2008; March 4, 2008; August 9, 2007; October 9, 2006; January 9, 2006, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement